• Samih Raad, Nasser Hanna, Shadia Jalal, Edmond Bendaly, Chen Zhang, Shashank Nuguru, Houssam Oueini, and Khalil Diab.
• Department of Medicine, the Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, Marion General Hospital Cancer Center, Marion, the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, the Pulmonary Medicine, Parkview Hospital, Fort Wayne, and the Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN.
• South. Med. J. 2018 Aug 1; 111 (8): 484-488.

ObjectivesEndobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the primary method for the diagnosis and staging of lung cancer. The purpose of this study was to assess the yield of EBUS-TBNA in the subtyping and genotyping of lung adenocarcinoma.MethodsSixty-nine patients at Indiana University Hospital and Sidney and Lois Eskenazi Hospital with possible or confirmed lung adenocarcinoma underwent EBUS-TBNA using a 21-gauge Olympus needle without suction. Samples were sent for molecular testing after rapid onsite specimen evaluation. A total of 6 to 10 passes were placed in a cell block.ResultsSixty-nine samples from patients with non-small-cell lung cancer were sent for molecular testing for epidermal growth factor receptor. Results were obtained in all of the patients. Mutations were found in three patients (4.3%). Fifty-eight samples were sent for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (100% yield), 10 of which had mutations (17.2%). Fifty-one samples were sent for proto-oncogene tyrosine-protein kinase ROS testing (1 [7.8%] mutant). Tissue samples were inadequate in three patients (94.1% yield). Sixty-three samples were sent for anaplastic lymphoma receptor tyrosine kinase testing (3 [4.8%] mutant, 6 [9.5%] inadequate, 90.5% yield).ConclusionsEBUS-TBNA with a 21-gauge needle is appropriate for the analysis of multiple mutations and the genotyping of lung adenocarcinoma.

23 keywords...

hide…